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Summary
Group A Streptococcus secretes cysteine proteases
namedMac-1andMac-2 thatmediatehost immuneeva-
sion by targeting both IgG and Fc receptors. Here, we
report the crystal structures of Mac-1 and its catalyti-
cally inactive C94A mutant in two different crystal
forms. Despite the lack of sequence homology, Mac-1
adopts the canonical papain fold. Alanine mutations
at the active site confirmed the critical residues in-
volved in a papain-like catalytic mechanism. Mac-1
forms a symmetric dimer in both crystal forms and dis-
plays the unique dimer interface among papain super-
family members. Mutations at the dimer interface re-
sulted in a significant reduction in IgG binding and
catalysis, suggesting that the dimer contributes to
both IgG specificity and enzyme cooperativity. A tun-
nel observed at the dimer interface constitutes a target
for designing potential Mac-1-specific antimicrobial
agents. The structures also offer insight into the func-
tional difference between Mac-1 and Mac-2.
Introduction
Group A Streptococcus (GAS) causes infections varying
in severity from uncomplicated strep throat to severe in-
vasive diseases, such as necrotizing fasciitis (‘‘flesh-
eating’’ syndrome) and streptococcal toxic shock syn-
drome (Cunningham, 2000). The human immune system
*Correspondence: psun@nih.govhas evolved several mechanisms by which to recognize
and clear the microorganism, including phagocytosis
and killing by polymorphonuclear leukocytes (PMNs);
complement-mediated cell lysis; and antibody-depen-
dent, cell-mediated cytotoxicity. GAS secretes a number
of factors, such as M protein, streptococcal inhibitor of
complement, superantigens, and streptococcal exo-
toxins, to evade host immunity (Lukomski et al., 1998;
Musser et al., 1991; Proft et al., 1999). Mac (also known
as IdeS) was recently identified as a new member of
GAS-secreted virulent factors. It shares limited homol-
ogy with the a subunit of the human leukocyte adhesion
glycoprotein Mac-1 (Lei et al., 2000, 2001; Pawel-Ram-
mingen et al., 2002). Characterization of the mac gene
revealed two divergent families of Mac variants desig-
nated as Mac-1 and Mac-2. The two variants differ pri-
marily in the middle one-third of the molecule, with
w50% amino acid identity in this region (Lei et al.,
2002). (Hereafter Mac-1 refers to the Mac protein from
strain MGAS5005, a representative of family I, and
Mac-2 represents a protein from strain MGAS8345 of
family II).
Immunoglobulins play a central role in host immunity.
In addition to the classical pathway of complement acti-
vation, the Fc region of bacterial surface bound opsoniz-
ing immunoglobulin G (IgG) mediates contact with
phagocytic cells carrying Fc receptors (Burton, 1985).
Bacterial pathogens have long targeted immunoglobu-
lins for their survival. For example, most gram-positive
bacterial pathogens encode antibody binding proteins
such as proteins A and G to inhibit antibody functions
by binding to the joint region between the CH2 and
CH3 domains of Fc (Bjorck and Kronvall, 1984; Gomi
et al., 1990; Heath and Cleary, 1987; Reis et al., 1984).
Mac-1 and Mac-2 block PMN opsonophagocytosis
and inhibit the production of reactive oxygen species
(ROS) (Lei et al., 2002). Recently, Mac-1 is shown to con-
tain IgG endopeptidase activity (Agniswamy et al., 2004;
Lei et al., 2002; Pawel-Rammingen et al., 2002). It recog-
nizes the lower hinge region of human IgG between the
CH1 and CH2 domains, similar to that recognized by the
Fcg receptors. This binding leads to proteolytic cleav-
age of the antibody. A site-specific mutant of Mac
(C94A) that lacked endopeptidase activity retained the
ability to bind IgG and block opsonization and phagocy-
tosis (Agniswamy et al., 2004; Lei et al., 2002). Mac-2, in
contrast, does not bind IgG. It displays micromolar bind-
ing affinity to Fcg receptors, resulting in the blockage of
IgG binding to the receptor (Agniswamy et al., 2004).
Integrins are heterodimeric membrane proteins on the
surface of mammalian cells that participate in cell-cell
adhesion and cellular differentiation, migration, and at-
tachment to the extracellular matrix (Ruoslahti, 1996).
An Arg-Gly-Asp (RGD) motif is critical for ligand recogni-
tion by many integrins (Wickham et al., 1993). Integrins
have been previously reported to bind microbial patho-
gens as diverse as Borrelia burgdorferi, Yersinia spp.,
Bordetella pertussis, GAS, adenovirus, foot-and-mouth
disease virus, and hantavirus through an RGD motif
(Gavrilovskaya et al., 1998; Isberg and Tran, 1994;
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226Table 1. Crystallographic Data Collection and Refinement Statistics
Native
Wild-Type
Se-Met C94A, Monoclinic Se-Met C94A, Orthorhombic
Native C94A Peak Remote Edge Peak Remote Edge
Wavelength (A˚) 0.97954 1.0001 0.9793 0.97166 0.97944 0.9793 0.97166 0.97944
Unit cell parameters (A˚) a = 63.87,
b = 87.12,
c = 57.6
a = 106.99,
b = 65.46,
c = 137.24,
b = 105.8
a = 108.13,
b = 65.48,
c = 138.29,
b = 106.5
a = 108.35,
b = 65.58,
c = 138.57,
b = 106.5
a = 108.79,
b = 65.78,
c = 139.14,
b = 106
a = 65.67,
b = 96.17,
c = 49.98
a = 65.62,
b = 96.08,
c = 50.02
a = 65.79,
b = 96.39,
c = 50.30
Space group P21212 P21 P21 P21 P21 P21212 P21212 P21212
Resolution range 50–2.4 50–2.0 50–2.5 50–2.6 50–2.7 50–2.6 50–2.7 50–2.8
Total observations 74,919 287,746 451,592 379,914 330,056 110,853 96,147 86,846
Unique reflections 11,918 114,364 61,605 53,255 46,510 10,075 8,964 8,183
Completeness 90.4 (50.3)a 92.8 (75.3) 96.9 (81.9) 92.8 (62.4) 91 (57.5) 98.7 (91.6) 97.6 (83.1) 97.8 (83.7)
I/s(I) 14.4 (1.98) 13.5 (1.5) 25 (4.2) 22.6 (3.7) 21.99 (3.6) 33.8 (3.7) 34.9 (3.2) 35.3 (3.1)
Rsym (%)
b 11 (31.4) 8.1 (33.9) 7.8 (20.6) 7.3 (21.3) 7.5 (22.4) 7.5 (18.5) 7 (21) 7.2 (24.8)
Phasing Statistics (45–2.6 A˚)
Phasing power 1.7
Rcullis (acentric) 0.62
FOM 0.22
Refinement Statistics
Resolution range 20–2.4 20–2.0
Rcryst (%)
c 21.6 21.8
Rfree (%)
d 26.6 26.7
Mean B factor (A˚2) 33.4 35.1
Number of protein atoms 2321 13901
Number of solvent atoms 96 995
Rmsd bond lengths (A˚) 0.009 0.009
Rmsd bond angles (º) 1.3 1.4
a Values in parentheses are given for the highest-resolution shell.
b Rsym = ShkljIhkl 2%IhklRj/ShklIhkl.
c Rcullis = SkFPh+(o) + FPh2(o)j 2 jFH+(c) 2 FH2(c)k/SjFPh+(o) + FPh2(o)j.
d R = SjFo 2 Fcj/SFo. Rfree is calculated with 5% of the randomly selected reflections.Mason et al., 1994). Mac-1 and Mac-2 bind human integ-
rins avb3 (also known as vitronectin receptor) and aIIbb3
(platelet glycoprotein IIb-IIIa). The ability of Mac-1 and
Mac-2 to interact with integrins suggests that endopep-
tidase activity of Mac-1 and Mac-2 may not be limited to
IgG (Lei et al., 2002).
To understand the molecular mechanism of Mac-me-
diated host-pathogen interactions, we have determined
the crystal structures of the wild-type and a catalytically
inactive C94A mutant of Mac-1 at 2.4 and 2.0 A˚, respec-
tively. The overall structure of Mac-1 is homologous to
proteins of the papain superfamily despite negligible se-
quence identity. Detailed analysis of the structure and
its implication on the function of Mac-1 and Mac-2 are
presented.
Results and Discussion
Overall Structure of Mac-1
The wild-type Mac-1 was crystallized in an orthorhom-
bic space group of P21212, and its mutant derivative
with the active site Cys94 replaced with alanine (C94A)
was crystallized in a monoclinic form of P21 (Table 1). Al-
though the C94A mutant lacked endopeptidase activity,
a solution binding study showed that it retained human
IgG binding ability with micromolar affinity, similar to
the wild-type Mac-1 enzyme. The mutant structure
was determined by SAD phasing and was refined to
2.4 A˚ (PDB code: 2AVW). The structure of wild-typeMac-1 was determined by molecular replacement by
using the partially refined C94A structure as the starting
model (PDB code: 2AU1). The structures of the wild-type
and C94A in the two different space groups are essen-
tially identical, except for the loop connecting strands
b7 and b8. This loop is undefined in the wild-type struc-
ture, but it has good electron density for all six mole-
cules in the asymmetric unit of the C94A crystal. No elec-
tron density was visible for the N-terminal 20 residues of
the wild-type and the 14 residues of the mutant Mac-1.
The 5 residues located at the N terminus (42–46) of
C94A form an additional b strand (b1) of an extended
antiparallel b sheet involving strands b2, b7, b8, b9,
b10, and b11. The last two C-terminal residues are dis-
ordered in all six molecules of the mutant.
Mac-1 adopts an a/b fold with 14 b strands and 9 a he-
lices (Figures 1A and 1B). The wild-type and C94A mu-
tant structures in two different crystal forms can be
readily superimposed, resulting in a root-mean-square
(rms) deviation varying from 0.5 to 0.7 A˚ for the six mu-
tant molecules (molecules A–F) in the asymmetric unit.
Mutant molecule F is most similar to the wild-type, and
molecule D deviates the most. Despite the lack of signif-
icant amino acid sequence identity, the crystal structure
of Mac-1 clearly adopts the fold of the papain super-
family of cysteine proteases. The N-terminal domain
(containing mostly residues from the first half of the se-
quence, 80–220 and 329–339) is made up predominantly
of a helices, whereas the C-terminal domain (containing
mainly residues from the second half of the sequence,
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227Figure 1. Structure of Mac-1 and Its Superposition with Actinidin and SpeB
(A) Ribbon diagram of Mac-1. The catalytic residues Cys94, His262, and Asp284 located at the interface of the N-terminal and C-terminal do-
mains are shown as ball-and-stick models. Secondary structures involved in dimerization are colored green. The position of the RGD motif is
shown in yellow (arrow).
(B) Comparison of the Mac-1 and Mac-2 sequences. Most of the amino acid differences occur in the middle one-third of the proteins. The RGD
motif involved in integrin binding is shown in yellow.
(C) Superposition of Mac-1 (in red) and actinidin (in yellow) shows their overall similar folds despite low amino acid sequence similarity. The sec-
ondary structures involved in dimerization are shown in green.
(D) Superposition of Mac-1 and SpeB, in red and cyan, respectively. The core structure of Mac-1 superimposes very well with SpeB.42–79 and 221–328) consists predominantly of b sheets.
The two domains are similar to those of actinidin (Baker,
1980), a member of the papain superfamily (Figure 1C). A
superposition between Mac-1 and actinidin resulted in
an rms deviation of 1.8 A˚ for a core of 91 Ca atoms. Major
secondary structural elements of actinidin are also pres-
ent in Mac-1. Similar to other superfamily members, the
C-terminal domain consists of an antiparallel b sheet,
but it is more extensive in Mac-1—it has two additional
strands, b1 and b2. Outside this conserved a/b core
(42% of the total residues in actinidin), Mac-1 contains
substantial insertions, making it considerably longer
(339 residues) compared to actinidin (218 residues), pa-
pain (212 residues), and other papain superfamily mem-
bers. The insertions form two helices (a2 and a5), two
strands (b5 and b6) in the N-terminal domain, and five
strands (b1, b3, b4, b12, and b13) in the C-terminal do-
main. The superposition of Mac-1 onto the published
IdeS structure (Wenig et al., 2004) resulted in an rms de-
viation of 0.4 A˚. Like SpeB (Kagawa et al., 2000), the only
other prokaryotic cysteine protease in the superfamily,
Mac-1 lacks disulfide bonds observed in actinidin and
papain. Despite less than 25% sequence identity, Mac-
1 can be superimposed with SpeB, resulting in an rms
deviation of 1.9 A˚ for 96 topologically equivalent Ca
atoms (Figure 1D).Active Site and Catalytic Mechanism of Mac-1
Cysteine 94 is the catalytic cysteine in Mac-1. It is cova-
lently bonded to a partially disordered BME molecule
present during protein purification (Figure 2A). Structur-
ally, Cys94 is located at the N-terminal end of helix a1
bordering the substrate binding cleft (Figure 3A). It has
an identical conformation to Cys25 of actinidin and
Cys25 of papain (Figure 3B). Previous mutagenesis stud-
ies (Lei et al., 2003) showed that His262 is essential for
the catalytic activity of Mac-1. The crystal structure
shows that His262 is hydrogen bonded to the catalytic
cysteine, analogous to His162 in actinidin and His159 in
papain (Figure 3B). In most of the enzymes of the papain
superfamily, an Asn residue completes the catalytic
triad. Mutagenesis of papain showed that the Asn side
chain is important for fixing the proper orientation of
the catalytic histidine (Vernet et al., 1995). The exception
to this rule is the GAS cysteine protease SpeB (Kagawa
et al., 2000), which acts through a simple Cys and His
pair, rather than a catalytic triad. In Mac-1, Asp284 is at
hydrogen bonding distance to His262 and completes
the catalytic triad, an arrangement similar to that seen
in the foot-and-mouth disease virus leader protease
(Figure 3A). In addition, Asp284 also forms a salt bridge
with Lys294 and van der Waals interactions with Tyr296
(Figure 3A). Consistent with the structural information,
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228Figure 2. Electron Density Maps around the
Active Site of the Mac-1 C94A Mutant
(A) The 2Fo 2 Fc electron density map (blue)
at the active site of Mac-1 wild-type con-
toured at a 1s cutoff. The Fo 2 Fc density
map is shown in red. The density indicates
that the g sulfur atom [SG] of catalytic C94
is covalently bonded to sulfur, presumably
from BME used during the protein purifica-
tion. The density is visible only for two atoms
of BME.
(B) The Fo 2 Fc electron density map of the
active site of the Mac-1 C94A mutant, con-
toured at 3s. The density fits very well with
a sulfate ion presumably contributed by the
crystallization precipitant. All six molecules
in the asymmetric unit of the mutant crystal
have a sulfate ion at the active site.solution binding studies showed that H262A and D284A
mutant proteins recognized human IgG1 with KDs of 52
and 56 mM, respectively. These values are 20-fold lower
than the binding affinity of wild-type Mac-1, confirming
the importance of the histidine and the orientation of its
imidazole ring in IgG recognition (Table 2).
Replacement of Asp286, Lys84, and Tyr255 with Ala
residues resulted in considerably decreased enzymatic
activity of Mac-1, suggesting that these residues partic-
ipate in catalysis or are important in maintaining the ar-
chitecture of the active site (Figures 4A and 4B). Lys84 is
analogous to Gln19 of actinidin and papain, a residue
that forms the presumed oxyanion hole together with
the peptide amide of the catalytic cysteine residue. No
detectable IgG1 binding was measured when Lys84
was mutated to Ala, confirming its role in oxyanion
hole formation (Table 2). In the Mac-1 C94A mutant
structure, a sulfate ion is present at the active site in all
six molecules (Figure 2B). One of the oxygens of the sul-
fate ion is hydrogen bonded to Nz of Lys84 and the pep-
tide amide of Cys94, presumably mimicking the interac-
tion between the main chain carbonyl group of the P1
residue of substrate and the oxyanion hole. The other
oxygens of the sulfate ion have hydrogen bonds to
His262, Arg259, and a water molecule. Almost all of
the cysteine proteases of the papain superfamily have
a conserved tryptophan adjacent to the catalytic Asn
or Asp that functions to shield the catalytic residues. In
Mac-1, Asp286 replaces this tryptophan and forms
a salt bridge with the oxyanion residue Lys84 to stabilize
the lysine residue. The absence of the conserved trypto-phan in the catalytic site provides room for the side
chain of Tyr255, which is unique to Mac-1, to make hy-
drogen bonds to Asp286, thereby fixing its orientation
and, in turn, the orientation of oxyanion Lys84.
To probe the importance of these residues in the rec-
ognition of IgG, SPR experiments were performed with
D286A and Y255A mutants. Each had 10-fold decreased
affinity for IgG compared to the wild-type enzyme, sup-
porting the role of Tyr255 and Asp286 in the integrity of
the oxyanion hole (Table 2). We next determined the en-
zyme kinetic parameters of various Mac-1 mutants by
BIAcore analysis to assess their importance in recogni-
tion and activity of the enzyme. Immobilized catalytically
inactive C94A mutant was used as a reporter to detect
residual intact immunoglobulins in these experiments.
The kinetic constants were determined by plotting the
reciprocal of the reaction velocity versus the reciprocal
of the substrate concentration (Lineweaver-Burk plot)
(Figure 4B). Y255A and D286A had a 3- to 4-fold increase
in Km and a 15- to 20-fold decrease in the overall cata-
lytic activity (kcat/Km) compared to the wild-type (Table
2). Alanine mutants of residues around the active site
Mac-1 and prosegment binding loop (PBL) of the papain
superfamily, F172A, N257A, V263A, K294A, and Y296A,
had similar Kms and catalytic activity (kcat/Km) as the
wild-type enzyme (Table 2).
Recognition of IgG by the Mac-1 Dimer
The Mac-1 C94A mutant crystals in the P21 space group
contain six molecules in the asymmetric unit arranged
as three identical 2-fold-related dimers betweenFigure 3. Active Site of Mac-1 and Its Com-
parison to the Papain Superfamily
(A) The catalytic triad and the residues
around the active site that play a vital role in
the activity of Mac-1 are displayed in a ball-
and-stick model.
(B) Superposition of the catalytic triad and the
oxyanion hole residues of Mac-1 (green) and
actinidin (magenta) used as a representative
of the papain superfamily. Asp286 of Mac-1
replaces the invariant tryptophan of the su-
perfamily.
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229molecules AB, CD, and EF stacked one above the other
along the dimer axis. Superposition of 289 Ca atoms
among the 6 molecules in the asymmetric unit resulted
in rms deviations ranging from 0.24 to 0.8 A˚. Figure 5A
shows one of the three dimers of C94A between mole-
cules A and B. This dimer is also present in the wild-
type Mac-1 structure in the P21212 crystal form, and
the dimer 2-fold is the crystallographic 2-fold. Each di-
mer buries approximately 1800 A˚2 surface area, repre-
senting 13% of the monomer surface.
The dimer association involves the protruding a5, b5,
and b6, which are part of the insertion regions of Mac-1
absent in actinidin and papain. They form two main con-
tact regions. First, the two-stranded (b5 and b6) antipar-
allel b sheet of one monomer hydrogen bonds to the
equivalent two-stranded antiparallel b sheet of the sec-
ond monomer. This interaction results in a four-stranded
Table 2. Enzymatic Kinetic Parameters of Mac-1 Mutants and the
Dissociation Constant for IgG1 Binding
Mac-1 Mutants
KD
(mM)
KM
(mM)
Vmax, nmoles 3
min21
kcat,
s21
kcat/KM, 10
3
M21 s21
Wild-type
Mac-1
2.6 6.8 0.13 0.12 17.6
K84A ND ND ND ND ND
M134L 12 5.6 0.15 0.14 25
F129I 223 112.4 0.52 0.01 0.09
F172A 6.2 5.6 0.15 0.14 25
Y255A 39.3 26.3 0.27 0.03 1.1
N257A 4.6 5 0.14 0.13 26
R259A 1.02 5.3 0.14 0.13 25
H262A 52 ND ND ND ND
V263A 5.6 4.8 0.14 0.13 27
D284A 56 ND ND ND ND
D286A 23 21.7 0.23 0.02 0.9
K294A 8.3 6.4 0.13 0.12 18.8
Y296A 2.2 4.5 0.13 0.12 26.7
ND: not detectableantiparallel b sheet that creates the core of the dimer in-
terface (Figure 5B). Phe129 of the two monomers is lo-
cated at the inner strands of the four-stranded antiparal-
lel dimer sheet forming the center of the dimeric
hydrophobic interface. Met134 of the two monomers
at the two outer strands completes the hydrophobic
core on the surface of the sheet. This hydrophobic
core is surrounded on either side by two interchain salt
bridges formed between equivalent Arg185 of one
monomer and Asp132 of the other and two intrachain
salt bridges between Asp132 and Lys159 of the same
molecule. The dimer interface is further stabilized by
two intermolecular hydrogen bonds between equivalent
Lys201 and Asn130 of the two molecules. Second, helix
a5 of one molecule packs against the equivalent helix of
the second monomer, creating a second point of con-
tact (Figure 5C). The main association between the two
helices is formed by the hydrophobic interactions be-
tween equivalent Tyr163, Thr166, and Lys167 residues
of the two molecules and the hydrogen bond between
Lys167 Nz and the peptide oxygen of Tyr163.
The two-stranded antiparallel b sheet in the Mac-1 di-
mer interface is replaced by a short helix in papain, acti-
nidin, and SpeB, and the a5 helical contact region of the
Mac-1 dimer is usually a random coil in papain, actinidin,
and SpeB. These key structural differences suggest that
dimerization is unique to Mac-l within the papain super-
family. In an effort to understand the relevance of the di-
mer in recognition of IgG by Mac-1, we mutated two di-
merization core residues: Phe129 to Ala and Ile, and
Met134 to Ala and Leu. Both Ala mutants formed insolu-
ble inclusion bodies when overexpressed, emphasizing
their importance in the structural integrity of Mac-1. The
effect of F129I and M134L mutations on dimer formation
was analyzed by size-exclusion chromatography and
was compared with the wild-type Mac-1, Mac-2, and ac-
tive site mutants C94A, N257A, and Y296A. Under the
gel filtration condition, w40% of the wild-type Mac-1Figure 4. Enzymatic Activity, Binding, and
Kinetic Parameters of Mac-1 Mutants
(A) SDS-PAGE, IgG endopeptidase assay of
Mac-1 mutants. Lane 1, molecular weight
marker; lane 2, human IgG; lane 3, human
IgG incubated with wild-type Mac-1; lane 4,
human IgG incubated with oxyanion hole mu-
tant K84A; lanes 5 and 6, IgG incubated with
dimer interface residue mutants F129I and
M134L, respectively; lanes 7–13, IgG incu-
bated with mutants (Y255A, N257A, R259A,
Y296A, K294A, F172A, and V263A, respec-
tively) around the active site and PBL of pa-
pain superfamily members.
(B) Lineweaver-Burk plots of Mac-1 mutant
activity on IgG1 with the Mac-1 mutant pro-
teins as reporters. The curves are labeled as
(solid diamond) R259A; (solid square) F129I;
(solid triangle) D286A; (solid circle) Y255A;
(cross) N257A; (open triangle) M134L; (open
square) V263A; (plus sign) Y296A; (minus
sign) K294A; (open circle) F172A.
(C) Superdex 200 elution profile of Mac-1 and
Mac-2 along with dimerization and active site
mutants M134L, F129I, Y296A, N257A, and
C94A. The dimer and monomer peaks are la-
beled.
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230Figure 5. Mac-1 Dimer Interface
(A) Ribbon diagram of the Mac-1 dimer. Di-
merization results in the two active sites be-
ing positioned on the top surface of each
monomer, as indicated by the arrows. The di-
mer interface is composed of helical and
sheet interactions, shown in green. The circle
indicates the position of the dimerization tun-
nel.
(B) Close-up view of the sheet interaction.
The two antiparallel b strands, b5 and b6, of
each monomer form a four-stranded antipar-
allel b sheet. At the top of this sheet, two salt
bridges and a pair of hydrogen bonds sur-
round a strong hydrophobic core formed by
equivalent Phe129 and Met134 contributed
by each of the two monomers.
(C) High-power view of the helices contribut-
ing to the dimer. Amino acid residues Tyr163,
Thr166, and Lys167 of each monomer play
a major role in helix interaction.
(D) Molecular surface view of Mac-1 colored
according to element. An arrow indicates
the tunnel at the dimerization interface.and active site mutants existed as dimers. When an iso-
lated monomer peak from the gel filtration was rein-
jected to the same gel filtration column, a repopulation
of dimer was observed, suggesting that the dimer/
monomer existed in equilibrium (data not shown). The
presence of dimers is reduced to 30% and 5%, respec-
tively, in M134L and F129I (Figure 4C).
The solution property of the protein was further stud-
ied by analytical ultracentrifugation. The sedimentation
profiles indicated the presence of a slow reaction on
the timescale of sedimentation, consistent with the per-
sistence of monomer and dimer populations in the gel
filtration experiments. The s-value of the C94A dimer
was estimated to be s20,w = 4.5 S, which is consistent
with the value of 4.7 S theoretically predicted from the
structure, within the typical deviations of hydrodynamic
predictions (Garcia De La Torre, 2000). Although the di-
merization reaction was far from saturation over the ac-
cessible concentration range, sedimentation velocity
permitted the precise measurement of the fractional
populations of monomers and dimers, which allowed
estimation of the dimerization constant under reversible
equilibrium by applying mass action law. For C94A, the
KD was estimated to be 2506 30 mM. For the F129I mu-
tant, due to the lower solubility of the protein leading to
trace level oligomerization, only a lower limit for the di-
merization constant of > 430 mM could be derived.
The affinities between M134L and F129I mutant pro-
teins and human IgG1 measured by SPR were 12 and
223 mM, or a 5- and 100-fold reduction, respectively,
compared to the wild-type. The conformation of F129I
was assessed by its ability to bind a rabbit anti-Mac an-
tibody with similar affinity as that of the wild-type (data
not shown). This reduced affinity of the M134L and
F129I mutants for IgG highlights the importance of di-
merization for immunoglobulin recognition. In addition
to reduced binding affinity, the catalytic activity mea-
sured for the F129I mutant is w200-fold lower than the
wild-type (Table 2). In fact, other than the catalytic triad
mutations, this dimer interface mutation resulted in the
most drastic reduction in kcat/KM. Dimerization of Mac-1positions the active site of each monomer at the top
of the dimer (Figure 5A). The distance between the two
active sites of the dimer is about 29 A˚. Importantly, the
distance between the Gly237 (a residue located at the
cleavage site) in the two heavy chains of the IgG1 Fc
fragment is w22 A˚ (Radaev et al., 2001). Given the
known flexibility of the IgG1 hinge region, it is possible
that the Mac-1 dimer recognizes both chains of antibody
in a symmetric fashion and cleaves them simulta-
neously. The 200-fold difference in activity between
the monomer (F129I) and dimer illustrates the coopera-
tivity resulting from the symmetric IgG recognition. This
is also in agreement with the Hill plot analysis of the
Mac-1 velocity curve reported by Vincents et al. (2004),
which predicted that the enzyme has two cooperative
sites. The lack of detectable binding in solution between
IgG1 and the oxyanion hole mutant K84A indicates that
the second binding site is not present on the same
monomer. This observation favors dimer-mediated rec-
ognition of IgG. The symmetric recognition of IgG by di-
meric Mac-1 also assumes importance considering the
fact that Mac-1 is secreted as a mature enzyme instead
of as a zymogen, as by other papain superfamily mem-
bers. That is, the dimerization of Mac-1 may be the
equivalent of zymogen activation of other cysteine pro-
teases. It is interesting that the dissociation KD for IgG
binding to wild-type Mac-1 (2.6 mM) is not only much
smaller than for the F129I mutant (223 mM), but it is
also much smaller than for dimer/monomer dissociation
(250 mM). In other words, the Mac-1 dimer is stable at
2.6 mM when bound to IgG. This suggests that IgG not
only prefers dimeric enzyme, but also stabilizes and pro-
motes the formation of the dimer.
The dimerization of Mac-1 results in a 9.5 A˚ diameter
and 18 A˚ long tunnel through the center of the dimer in-
terface (Figure 5D). Sheet interaction of the dimer forms
the floor of the tunnel and is hydrophobic with residues
Phe129, Met134, and Pro203 from each monomer. The
helical interaction of the dimer forms the tunnel roof,
which is lined with the hydrophic and polar residues
Pro162 and Tyr163 of both monomers. The walls of the
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231Figure 6. Inhibitory Profile of Mac-1
(A) The superposition of actinidin, SpeB, and
Mac-1 PBL. The loop traces a completely dif-
ferent direction in actinidin when compared
to Mac-1 and SpeB.
(B) Residues of the PBL equivalent loop of
Mac-1 that block the active site, shown in
a ball-and-stick model, along with the cata-
lytic triad of the C94A mutant. Leupeptin is
shown as a magenta ball-and-stick model
as it binds in actinidin. The position of the
PBL equivalent loop creates steric clashes
with the inhibitor, indicating that the active
site entry is in a closed conformation.
(C) Common inhibitors of cysteine proteases
like E64 (red) and Leupeptin that bind to the
S1–S3 specificity pocket are blocked by the
PBL equivalent loop and the loop connecting
helices a5 and a6 (magenta), thereby render-
ing this class of inhibitors inactive. Inhibitors
like TLCK (green) and TPCK bind at the ac-
cessible S1–S20 pockets, resulting in inhibi-
tion of the enzyme.
(D) Amino acid variations in Mac-2 when
compared to Mac-1 represented as a stick
model in the Mac-1 structure. The middle
one-third of the residue in which the differ-
ences occur is shown in red. Except for
Y255C, all other amino acid variations are
on surface regions in the N-terminal domain,
suggesting that the overall folds of Mac-2
and Mac-1 will be same.tunnel are charged with carbonyl oxygens of Lys159 and
Ala160 and side chains of Asp202 and Arg204. The tun-
nel mouths are lined with the mostly hydrophilic resi-
dues Lys89, Glu132, Glu158, Lys159, Arg185, Ser187,
and Thr189. The cooperative dimer function suggests
a potential novel class of inhibitors to target the dimer-
ization region of the enzyme. As shown in the F129I mu-
tation, failure to form a dimer would lead to a drastic re-
duction in the enzyme activity. Compounds that bind in
the tunnel and disrupt the Mac-1 dimer formation would
result in inhibition of the enzyme activity. Unlike the ex-
isting active site inhibitors that tend to be broadly reac-
tive, the dimerization inhibitor is anticipated to be spe-
cific against the bacterial enzyme and, thus, a potential
antibacterial agent.
Prosegment Binding Loop of the Papain Superfamily
Unlike other members of the papain superfamily, Mac-1
is secreted as a mature enzyme rather than as an inac-
tive proenzyme. The prosegment present in other super-
family members packs against an 18 residue proseg-
ment binding loop (PBL), residues 137–155 in papain,
residues 138–156 in cathepsin K (Sivaraman et al.,
1999), and residues 138–155 in cathepsin L. The loop
equivalent to PBL in Mac-1 is between strands b8 and
b9 from Thr254 to Asn261 in the C-terminal domain. It
is only 7 residues long and appears disordered in the
electron density of the wild-type Mac-1, but it is present
in good electron density in all six molecules of the C94A
mutant. Among the six molecules, only Thr254 and
Tyr255 in the PBL loop of molecule D and Thr254 of mol-
ecule F are hydrogen bonded to neighboring molecules,
while molecules A, B, C, and E are not, suggesting that
the observed PBL conformation in C94A mutant is nota result of crystal packing. The PBL loop of Mac-1
adopts a very different conformation from those in acti-
nidin and other papain-class enzymes (Figure 6A). Inter-
estingly the PBL loop in the proenzyme structure of
SpeB is also short and assumes a similar conformation
as in Mac-1. The conformation of the equivalent PBL
loop in Mac-1 is stabilized by hydrogen bonds between
the side chain of Arg259 and the peptide amide of
Asn261 as well as the oxygen of a sulfate ion in the active
site, and by the hydrogen bonds between Od1 and Nd2 of
Asn257 and the peptide of Asn261 (Figure 6B). Since
both Asn257 and Asn261 are also part of the putative
substrate binding site, the conformation of PBL in
Mac-1 appears to partially block the substrate binding.
However, the solution binding studies with the Ala muta-
tions of Asn257 and Arg259 show that these mutants
display similar affinity and catalytic activity to IgG as
that of wild-type Mac-1 (Figure 4B; Table 2), suggesting
that the substrate induces a conformational change in
the putative PBL loop.
Structural Basis of Mac-1 Inhibitor Binding
Previous studies established that several cysteine pro-
tease inhibitors did not inhibit Mac-1. For example, the
most common cysteine protease inhibitors, such as
E64, Leupeptin, and Cystatin, inhibited Mac-1 ineffi-
ciently, whereas small molecules such as TLCK, TPCK,
and iodoacetamide inhibited Mac-1 efficiently (Agnisw-
amy et al., 2004). The structure of Mac-1 provided insight
into the inhibition profile observed for this enzyme. Inhib-
itors like E64 and Leupeptin target enzyme subsites S1,
S2, and S3 (Schroder et al., 1993; Varughese et al., 1992).
The absence of an invariant disulfide bond in the loop be-
tween helices a5 and a6 in Mac-1 causes the loop to
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duced S2 and S3 pockets (Figure 6C). The Leu169 of
this loop, which is an alanine in papain and actinidin,
may also hinder the binding of the P3 residue of E64. In
contrast, TLCK and TPCK bind to the S1, S10, and S20
sites that are available (Figure 6C).
Mac-2 Features Inferred on the Basis of the Mac-1
Structure
Studies of variation in themac gene identified 31mac al-
leles that would encode 31 distinct Mac proteins
grouped into 2 different groups designated as Mac-1
and Mac-2 (Lei et al., 2002). Mac variants were closely
related within each group, but they shared w80% se-
quence homology between the groups. Most of the
amino acid differences occur in the middle one-third of
the protein, where the two groups differ at about 50%
of their residues (Figure 1B). Inasmuch as Mac-1 and
Mac-2 differ in many functional attributes, we mapped
the divergent region in Mac-2 onto the Mac-1 crystal
structure. With the exception of Y255C, all variant amino
acids were located in the N-terminal domain on the sur-
face-exposed face of the helices and loops (Figure 6D).
The active site residues of Mac-1 are conserved in
Mac-2, except Tyr255, which is a cysteine in Mac-2 (Fig-
ure 3A). Since Tyr255 stabilizes the oxyanion conforma-
tion, and since the Ala mutation of the residue resulted in
a significant decrease in enzymatic activity, the cysteine
replacement most likely contributes to the lower endo-
peptidase activity observed in Mac-2 (Agniswamy
et al., 2004; Lei et al., 2002). The dimerization interface
of Mac-1 is conserved in Mac-2, except Met134 is
changed to Leu, similar to the M134L mutant of Mac-1,
suggesting that the dimer structure is conserved in
Mac-2. A gel filtration experiment showed that Mac-2
also forms a dimer in solution.
In addition to the reduced endopeptidase activity
against IgG, Mac-2 also displays binding, but not endo-
peptidase, activity toward the Fc receptor (Agniswamy
et al., 2004). This suggests that the Fc receptor binding
site is distinct from that of IgG binding. The concentra-
tion of amino acid substitutions on the solvent-accessi-
ble side of the loops and helices of the N-terminal do-
main suggests that Mac-2 uses this region to interact
with the Fc receptors.
Integrin Binding of Mac-1 and Mac-2
Another notable site of variation from the papain super-
family members is the region (amino acid residues 182–
221) connecting the a6 helix and the b7 sheet that folds
into two loops separated by a one-turn helix, helix a7.
The loop connecting a7 and b7 has an RGD (214–216) in-
tegrin binding motif (Wickham et al., 1993). Both Mac-1
and Mac-2 have this RGD motif. Cell-based binding
studies showed that both Mac-1 and Mac-2 bind to hu-
man integrin avb3 (also known as vitronectin receptor)
and aIIbb3 (platelet glycoprotein IIb-IIIa) (Lei et al.,
2002). In the Mac-1 structure, the RGD motif is solvent
exposed, consistent with its role in binding a divalent
metal on the integrin receptor (Figures 1B and 6D) (Ber-
gelson and Hemler, 1995). All other members of the pa-
pain superfamily lack the RGD motif in the analogous re-
gion. Interestingly, SpeB also has an RGD motif and
binds to integrins avb3 and aIIbb3. However, the RGD mo-tif in SpeB is located on the surface loop inserted at the
C-terminal end of b7, placing it in the C-terminal domain,
whereas, in Mac-1, the RGD motif is located in the loop
before b7 in the N-terminal domain. It is important to
note that the RGD loop of Mac-1 is away from the active
site, implying a recruitment function through the RGD
motif to position the protease near the complement
complex for catalysis. This ability of Mac-1 to interact
with proteins present on the surface of host cells while
maintaining an exposed active site suggests an elegant
strategy for disrupting host immune defenses and con-
tributing to pathogenesis.
Concluding Remarks
Taken together, our results show that in spite of virtually
no sequence similarity to known cysteine proteases,
Mac-1 adopts a fold of the papain superfamily with
a number of distinct features around its active site. Im-
portantly, the structures revealed that Mac-1 is a dimer
in both crystal forms, and that, to our knowledge, the
structural elements involved in dimerization are unique
to Mac-1 within the papain superfamily. The structures
and mutational data support the importance of the di-
merization of Mac-1 in both the substrate specificity
and the enzyme cooperativity. The dimerization tunnel
opens a new, to our knowledge, avenue for the design
of Mac-1-specific inhibitors. The structure also revealed
the importance of Tyr255 in substrate recognition, sug-
gesting that its substitution by cysteine is responsible
for the reduced IgG binding affinity and endopeptidase
activity observed for Mac-2. The blocked S2 and S3
pockets are responsible for the inactivity of commonly
used inhibitors of cysteine proteases like E64 and Leu-
peptin against Mac-1. Inhibitors such as TLCK that
bind at the accessible S1 to S20 pockets should result
in loss of enzyme activity. Thus, GAS has evolved an en-
zyme that is highly specific and ideal for contributing to
evasion of human immune defenses.
Experimental Procedures
mac Gene Mutagenesis and Purification of Recombinant Mac
The mac gene was mutated as described previously (Lei et al., 2002,
2003), by using oligonucleotides listed in Table 3. Recombinant Mac
protein was overexpressed and purified to apparent homogeneity as
described previously (Lei et al., 2002), with the following modifica-
tions. Recombinant Mac and Mac mutants were purified from E.
coli strains grown at 37ºC in 4 L Luria-Bertani broth supplemented
with 100 mg ampicillin per liter. Expression of recombinant protein
was induced by adding isopropyl-1-thio-b-D-galactopyranoside at
an OD600nm of 0.6, and cells were harvested after 4.5 hr. Cells were
pelleted by centrifugation, suspended in 40 ml 10 mM Tris-HCl buffer
(pH 8.0), and sonicated for 15 min at 4ºC. All buffers used in the mod-
ified purification protocol had 10 mM Tris-HCl (pH 8.0) in place of the
sodium phosphate buffers used in the initial purification protocol.
The selenomethionyl derivative of the recombinant C94A Mac mu-
tant was made by usingE. coli strain DL41 (Met2) containing plasmid
pSP22 and was grown in a chemically defined glucose medium sup-
plemented with selenomethionine in place of methionine. The sele-
nomethionyl protein was purified in a manner similar to that of the
wild-type.
SDS-PAGE Endopeptidase Cleavage Assay and Gel Filtration
The ability of Mac to cleave IgG was studied by incubating 20 mg hu-
man IgG (Bethyl Laboratories) with 1 mg Mac in phosphate-buffered
saline at 37ºC for 90 min. Mac was activated by incubating it with
1 mM dithiothreitol (DTT) at 4ºC for 20 hr. The DTT was removed
by changing the buffer three times with a Centricon (10,000 MWCO)
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233centrifugal device (Amicon). The endopeptidase activity of Mac mu-
tants was analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) under reducing conditions with Coomassie blue staining.
Gel filtration of Mac-1, Mac-1 dimer mutants F129I and M134L, and
active site mutants C94A, N257A, and Y296A was performed on an
Amersham Pharmacia Superdex 200 column in 20 mM Tris and 20
mM NaCl buffer (pH 8.0) with a flow rate of 1 ml/min. All samples
were prepared at 4 mg/ml (w100 mM) concentration. The column di-
mensions were 30 3 1 cm, and 0.5 ml fractions were collected for
analysis. The profile of molecular weight standards, bovine serum al-
bumin, ovalbumin, and ribonuclease A, was used to assign the
monomer and dimer peaks.
Surface Plasmon Resonance Measurements and Determination
of Enzymatic Rate Constants
Surface plasmon resonance (SPR) measurements were performed
with a BIAcore 3000 instrument (BIAcore AB). Mac-1 mutants were
immobilized on a CM5 sensor chip at concentrations of 3 mM in
5 mM sodium acetate (pH 5.5–6.0), by using N-hydrosuccinimide/
1-ethyl-3(-3-dimethlaminopropyl) carbodiimide hydrochloride (NHS/
EDC) at a flow rate of 10 ml/min. Flow cell 1 of every sensor chip was
mocked with NHS/EDC as a blank control. All binding and kinetic ex-
periments were performed at room temperature with HBS-EP (BIA-
core AB) as running buffer. The immobilization level varied from
500 to 2500 response units. Dissociation constants (KD) were ob-
tained by linear regression of steady-state 1/Response versus 1/C
plots or from kinetic rate constants fitted with the BIAevaluation soft-
ware package (BIAcore AB). The binding affinity of a rabbit anti-Mac
antibody to immobilized dimerization mutant F129I was measured
with serial dilution of the antibody varying from 0.5 mM to 7.8 nM.
To determine the enzyme kinetic parameters of Mac-1 mutants for
IgG1, kinetic binding experiments were performed on CM5 BIAcore
sensor chips immobilized with an enzymatically inactive C94A Mac-1
mutant that retained IgG binding. For mutants M134L, F172A, N257A,
R259A, K294A, and Y296A, the analyte consisted of 2 mM immuno-
Table 3. Mac Amino Acid Replacements and Primers
SIaA Mutant Primer (50 to 30)
K84A GGATGGTATGATATTACCGCAACATTCAATG
GAAAAGACG
CGTCTTTTCCATTGAATGTTGCGGTAATAT
CATACCATCC
F1291 GCAAAAAATAAACATCAATGGCGAACAGATG
CATCTGTTCGCCATTGATGTTTATTTTTTGC
Ml 34L CTTCAATGGCGAACAGCTGTTTGACGTAAA
AGAAGC
GCTTCTTTTACGTCAAACAGCTGTTCGCCA
TTGAAG
Fl 72A CTAAACACCTAGGAGTTGCCCCTGATCATGT
AATTGATATG
CATATCAATTACATGATCAGGGGCAACTCC
TAGGTGTTTAG
Y255A GGCCTATCACACACCGCCGCTAACGTACGCATC
GATGCGTACGTTAGCGGCGGTGTGTGATAGGCC
N257A CCTATCACACACCTACGCTGCCGTACGCATCAA
CCATG
CATGGTTGATGCGTACGGCAGCGTAGGTGTGTG
ATAGG
R259A CACCTACGCTAACGTAGCCATCAACCATGTTAT
AAACC
GGTTTATAACATGGTTGATGGCTACGTTAGCGTA
GGTG
V263A CGTACGCATCAACCATGCTATAAACCTGTG
GGGAGC
GCTCCCCACAGGTTTATAGCATGGTTGAT
GCGTACG
K294A GCATCTATTGGTATGGCGAAATACTTTGTTGGTG
CACCAACAAAGTATTTCGCCATACCAATAGATGC
Y296A GCATCTATTGGTATGAAGAAAGCATTTGTTGGTG
CACCAACAAATGCTTTCTTCATACCAATAGATGCglobulin mixed with 10 nM respective mutants. For the Y255A and
D286A mutants, the analyte contained 2 mM immunoglobulin and
100 nM mutants. For the F129I mutant, 2 mM IgG1 with 400 nM
F129I was used as the analyte. The residual binding of immunoglob-
ulin to the immobilized reporter C94A upon Mac-1 digestion was as-
sayed kinetically every 5 min at room temperature to detect and
quantify the residual substrate concentration and, thus, the con-
centration of product formed. A 20 mM glycine buffer at pH 9.5 was
used for regenerating the C94A Mac-1 flow cell. The kinetic con-
stants (Km, Vmax, and kcat) were determined by Lineweaver-Burk plot.
Sedimentation Velocity Analytical Ultracentrifugation
Sedimentation velocity experiments were conducted with Beckman
Optima XLI, applying the experimental protocol described in detail
elsewhere (Balbo and Schuck, 2005). In brief, 200 ml samples at
10-fold range of loading concentrations were centrifuged at 19ºC
and 50,000 rpm, and the concentration gradients were recorded
with the Rayleigh interferometric optical system. Protein partial-spe-
cific volumes and buffer density and viscosity were calculated from
tabulated data by using the software SEDNTERP (kindly provided by
Dr. J. Philo). Data were modeled as a continuous distribution of sed-
imentation coefficients, c(s) (Schuck, 2000), by using the software
SEDFIT (Schuck, 2005). No significant concentration-dependent
change of peak positions was observed. Alternatively, the data
were modeled globally as a set of discrete monomer and dimer spe-
cies in combination with continuous distributions describing trace
impurities, by using the software SEDPHAT (Schuck, 2005). Both
models resulted in residuals on the order of the noise of data acqui-
sition. The latter model was used to estimate the populations of
monomer and dimer, from which the dimerization equilibrium con-
stant was estimated by using the population isotherm model of
SEDPHAT (Schuck, 2005). The sedimentation coefficient of the C94A
dimer was predicted from the crystal structure coordinates by using
the program HYDROPRO (Garcia De La Torre et al., 2000).
Crystallization and Data Collection
Crystals of Mac-1 were grown in hanging drops at 4ºC by mixing 1 ml
protein solution (14 mg/ml of protein) and reservoir solution (1.3 M
ammonium sulfate, 0.1 M sodium citrate [pH 4.8]). The crystals
were orthorhombic, of space group P21212, and had unit cell dimen-
sions of a = 63.87, b = 87.12, c = 57.6 and one molecule per asym-
metric unit (solvent content 45.8%). The crystals were frozen with
cryoprotectant containing 0.8 M lithium sulfate, 0.1 M sodium citrate
(pH 4.8), and 25% glycerol. The C94A mutant and its SeMet-
substituted form were grown by microseeding with the wild-type
crystals in hanging drops at room temperature with the protein (12
mg/ml) and the precipitant (1.5 M ammonium sulfate, 0.1 M sodium
citrate [pH 4.8]) mixed at a 1:1 ratio. The crystals belonged to a mono-
clinic space group P21 with unit cell parameters of a = 107.8, b =
65.14, c = 137.99, b = 106.23º and six molecules per asymmetric
unit (solvent content 43.9%). The cryoprotectant used was the
same as that used for the wild-type crystals. Diffraction data were
collected at 100 K on beamline 22-ID of the Southeast Regional Col-
laborative Access Team (SER-CAT) at the Advanced Photon Source,
Argonne National Laboratory. Supporting institutions may be found
at www.ser.anl.gov/new/members.html. Multiwavelength anoma-
lous diffraction data were collected at three wavelengths on a single
Se-Met crystal of the C94A mutant enzyme. A native data set was
also collected from a single crystal of the C94A mutant. All data
were integrated and scaled with HKL2000.
Structure Determination and Refinement
Attempts to solve the structure of the C94A mutant from a monoclinic
data set by the multiwavelength anomalous diffraction method
failed to produce a good interpretable map, although 18 of the 24
possible selenium sites, excluding the N-terminal Met residue,
were identified by both SHELXD (Schneider and Sheldrick, 2002)
and SNB (Weeks and Miller, 1999). The incorporation of noncrystal-
lographic symmetry (NCS) operators identified from the selenium
sites did not improve the quality of the phases. Trials with different
algorithms, such as SHARP (Bricogne et al., 2003), CNS (Bru¨nger
et al., 1998), and CCP4 (1994), with the 18 sites did not produce
good phases. Interestingly, one-third of the monoclinic diffractions
appear to form a pseudoorthorhombic space group P21212 similar
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234to that of the wild-type crystals. Additional details on how this sub-
set of data was used for structure solution will be discussed in a dif-
ferent publication. With one molecule per asymmetric unit in the
pseudoorthorhombic form, all four selenomethionines, except the
N terminus, were identified by CNS, Solve (Terwilliger and Berend-
zen, 1999), SHELXD, and Shake and Bake. The data set collected
at the peak wavelength of Se was used to determine the structure
of the C94A mutant, as the addition of two other wavelengths cor-
rupted the quality of the phases, probably due to radiation damage.
Initial phases from CNS were solvent flattened with density modifi-
cation in CNS, which resulted in a good interpretable map. Model
building into the experimental map performed with the program O
(Jones et al., 1991) identified most of the secondary structural ele-
ments, except some loop regions. The partially refined pseudo or-
thorhombic C94A structure at this stage was used as the starting
model for the molecular replacement to solve the wild-type Mac-1
structure. This produced an interpretable electron density map for
modeling and refinement of the wild-type structure by using CNS
with periodic model rebuilding with the program O. The final R and
Rfree were 21.6 and 26.4, respectively, for data in the range of 30–
2.4 A˚. The model conforms well to protein geometry and is validated
by Ramachandran plot with no disallowed f/c values. The refined
wild-type Mac-1 structure was used as a starting model to solve
the original P21 data set of C94A by molecular replacement with
CNS. The refined R and Rfree were 21.8 and 26.7, respectively, for
data in the range of 30–2.0 A˚. Surface area calculations were made
with CONTACT and AREAIMOL (1994). Molecular figures were pre-
pared with Molscript, Raster3D (Merritt and Murphy, 1994), PyMOL
(DeLano Scientific, 2005), and GRASP (Nicholls et al., 1991).
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